Download PDF
Synfacts 2020; 16(02): 0220
DOI: 10.1055/s-0039-1691636
Chemistry in Medicine and Biology
© Georg Thieme Verlag Stuttgart · New York

A First-in-Class, Clinically-Relevant Covalent Inhibitor of KRAS(G12C)

Contributor(s):
Dirk Trauner
,
Bryan S. Matsuura
Further Information

Publication History

Publication Date:
21 January 2020 (online)

    Permissions and Reprints

Key words

KRAS(G12C) - covalent inhibitors - oncology